Resignation of Dr. Robert Dean

ViaLogy PLC ("ViaLogy" or "the Company")

Resignation of Dr. Robert Dean

The Board of ViaLogy announce the resignation of Dr. Robert Dean with immediate effect from the Board of ViaLogy by mutual consent.

Dr. Dean will receive no payment but will be entitled to his options granted to him on 19 March 2014

Dr. Sandeep Gulati, who is CEO of VEC and Chief Technology Officer of the Company, will report directly to Adam Reynolds, who will fulfill the role as interim CEO and Executive Chairman.

For further information:

ViaLogy PLC

Mark Collingbourne

mark.collingbourne@vialogy.com

Nominated Advisor to ViaLogy PLC (Cantor Fitzgerald Europe)

Mark Percy / Catherine Leftley - Corporate Finance +44 (0) 207 894 7000